Urovant Sciences Majority Shareholder, Roivant Sciences, and Sumitomo Dainippon Pharma Complete Transaction for Strategic Alliance
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec 30, 2019--Urovant Sciences (Nasdaq: UROV) (“Urovant”) announced today that its majority shareholder, Roivant Sciences...
Read more


















